Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multiple Sclerosis Relapse”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT04833673
What this trial is testing

The Effects of Relaxation Techniques on Pain, Fatigue and Kinesiophobia in Multiple Sclerosis Patients: A Three Arms Randomized Trial

Who this might be right for
Multiple Sclerosis, Relapsing-RemittingPain, ChronicFatigue Syndrome, Chronic+1 more
Hacettepe University 80
Testing effectiveness (Phase 2)Temporarily pausedNCT04909502
What this trial is testing

Evaluation of Safety, Tolerability and Preliminary Efficacy of EHP-101 in Relapsing Forms of Multiple Sclerosis

Who this might be right for
Relapsing Forms of Multiple Sclerosis
Emerald Health Pharmaceuticals 50
Post-approval studies (Phase 4)Study completedNCT01623596
What this trial is testing

Evaluation of Patient Retention of Fingolimod vs. Currently Approved Disease Modifying Therapy in Patients With Relapsing Remitting Multiple Sclerosis.

Who this might be right for
Relapsing Remitting Multiple Sclerosis
Novartis Pharmaceuticals 881
Not applicableStudy completedNCT01601080
What this trial is testing

An Observational, Retrospective, UK & Ireland Audit of Patient Adherence to Rebif® Injections Using the RebiSmart™ Injection Device

Who this might be right for
Relapsing Multiple Sclerosis
Merck KGaA, Darmstadt, Germany 230
Testing effectiveness (Phase 2)Study completedNCT05798520
What this trial is testing

Learn About the Safety of BIIB091 and Its Effect on Brain Inflammation When Taken Alone or With Diroximel Fumarate (DRF) in Adults With Relapsing Forms of Multiple Sclerosis (MS)

Who this might be right for
Relapsing Forms of Multiple Sclerosis
Biogen 127
Testing effectiveness (Phase 2)Study completedNCT00525668
What this trial is testing

Sunphenon Epigallocatechin-gallate (EGCg) in Relapsing-remitting Multiple Sclerosis (SuniMS Study)

Who this might be right for
Relapsing-remitting Multiple Sclerosis
Charite University, Berlin, Germany 120
Not applicableStudy completedNCT01075880
What this trial is testing

Post-Authorization Observational Study to Evaluate Cognition and Fatigue in Relapsing-remitting Multiple Sclerosis (RRMS) Patients Treated With Rebif®

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Merck KGaA, Darmstadt, Germany 300
Post-approval studies (Phase 4)Study completedNCT04869358
What this trial is testing

Exploring the Immune Response to SARS-CoV-2 COVID-19 Vaccines in Patients With Relapsing Multiple Sclerosis (RMS) Treated With Ofatumumab

Who this might be right for
Relapsing Multiple Sclerosis
Novartis Pharmaceuticals 34
Early research (Phase 1)Study completedNCT02193217
What this trial is testing

Explore the Cardiac Pharmacodynamics of MT-1303

Who this might be right for
Relapsing-remitting Multiple Sclerosis
Tanabe Pharma Corporation 81
Testing effectiveness (Phase 2)UnknownNCT04150549
What this trial is testing

FMT for MS Patients

Who this might be right for
Multiple Sclerosis
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 34
Not applicableUnknownNCT04857489
What this trial is testing

Deficient T Regulatory Cell (Treg) Function in Patients With Relapsing Remitting Multiple Sclerosis

Who this might be right for
Relapse Remitting Multiple Sclerosis
Thomas Jefferson University 80
Testing effectiveness (Phase 2)WithdrawnNCT00104143
What this trial is testing

A4I Antagonist in Patients With Relapsing Multiple Sclerosis.

Who this might be right for
Multiple Sclerosis
Hoffmann-La Roche
Large-scale testing (Phase 3)Active Not RecruitingNCT04926818
What this trial is testing

Efficacy and Safety of Ofatumumab and Siponimod Compared to Fingolimod in Pediatric Patients With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis (MS)
Novartis Pharmaceuticals 129
Testing effectiveness (Phase 2)Study completedNCT01973491
What this trial is testing

ATX-MS-1467 in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Merck KGaA, Darmstadt, Germany 37
Not applicableStudy completedNCT04756687
What this trial is testing

Real World Analysis on Lymphocyte Reconstitution After Lymphopenia in Participants Treated by Tecfidera

Who this might be right for
Multiple SclerosisMultiple Sclerosis, Relapsing-Remitting
Biogen 1,507
Not applicableUnknownNCT06516458
What this trial is testing

Development of Camera Based Gait Quality Measure for Persons With Multiple Sclerosis

Who this might be right for
Multiple SclerosisMultiple Sclerosis, Secondary ProgressiveMultiple Sclerosis Relapse+1 more
Shirley Ryan AbilityLab 40
Testing effectiveness (Phase 2)Study completedNCT01717664
What this trial is testing

Proof of Concept Study of RHB-104 as Add-On Therapy to Interferon Beta-1a in Relapsing Remitting Multiple Sclerosis (RRMS)

Who this might be right for
Relapsing Remitting Multiple Sclerosis
RedHill Biopharma Limited 18
Not applicableStudy completedNCT02021162
What this trial is testing

Effects of Gilenya (Fingolimod) on Thalamus Pathology and Cognitive Impairment in Patients With Relapsing Forms of Multiple Sclerosis

Who this might be right for
Multiple SclerosisHealthy
University at Buffalo 50
Not applicableUnknownNCT04380220
What this trial is testing

Coagulation/Complement Activation and Cerebral Hypoperfusion in Relapsing-remitting Multiple Sclerosis

Who this might be right for
Multiple SclerosisRelapse
Regina Elena Cancer Institute 80
Not applicableStudy completedNCT05438693
What this trial is testing

Delayed Diagnosis of Multiple Sclerosis, Treatment Initiation and Non-adherence in Upper Egypt

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
doaa mokhtar mahmoud 80
Next Page